ATE509951T1 - Humanes interferon-beta-mutein - Google Patents

Humanes interferon-beta-mutein

Info

Publication number
ATE509951T1
ATE509951T1 AT05804508T AT05804508T ATE509951T1 AT E509951 T1 ATE509951 T1 AT E509951T1 AT 05804508 T AT05804508 T AT 05804508T AT 05804508 T AT05804508 T AT 05804508T AT E509951 T1 ATE509951 T1 AT E509951T1
Authority
AT
Austria
Prior art keywords
human interferon
interferon beta
beta mutein
mutein
beta
Prior art date
Application number
AT05804508T
Other languages
English (en)
Inventor
Moon Kyoung So
Jong-Min Lee
Ji-Hye Yang
Kyung Song
Jae Ho Jin
Young Kee Shin
Han Kyu Oh
Ji Tai Kim
Ji Soo Ahn
Ji Uk Yoo
Tae Ho Byun
Ho Chul Yoon
Original Assignee
Young Kee Shin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Young Kee Shin filed Critical Young Kee Shin
Application granted granted Critical
Publication of ATE509951T1 publication Critical patent/ATE509951T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05804508T 2004-11-02 2005-11-02 Humanes interferon-beta-mutein ATE509951T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020040088196A KR100781666B1 (ko) 2004-11-02 2004-11-02 인간 인터페론-베타 변이체
PCT/KR2005/003665 WO2006049423A1 (en) 2004-11-02 2005-11-02 Human interferon-beta mutein

Publications (1)

Publication Number Publication Date
ATE509951T1 true ATE509951T1 (de) 2011-06-15

Family

ID=36319397

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05804508T ATE509951T1 (de) 2004-11-02 2005-11-02 Humanes interferon-beta-mutein

Country Status (11)

Country Link
US (1) US8101716B2 (de)
EP (1) EP1809661B1 (de)
JP (1) JP4637913B2 (de)
KR (1) KR100781666B1 (de)
CN (1) CN101111519B (de)
AT (1) ATE509951T1 (de)
BR (1) BRPI0517932B1 (de)
DK (1) DK1809661T3 (de)
ES (1) ES2369088T3 (de)
PT (1) PT1809661E (de)
WO (1) WO2006049423A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006020580A2 (en) * 2004-08-09 2006-02-23 Alios Biopharma Inc. Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
US8114630B2 (en) 2007-05-02 2012-02-14 Ambrx, Inc. Modified interferon beta polypeptides and their uses
CN102260344A (zh) * 2010-05-26 2011-11-30 重庆富进生物医药有限公司 缺失型人β干扰素及其重组制备
DK2762489T3 (en) 2011-10-01 2018-07-02 Glytech Inc GLYCOSYLED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
SG11201507769SA (en) 2013-03-29 2015-10-29 Glytech Inc Polypeptide having sialylated sugar chains attached thereto
CN106132983B (zh) 2014-04-04 2021-03-26 阿雷斯贸易股份有限公司 新型IFN-β蛋白类似物
KR101671501B1 (ko) * 2014-07-24 2016-11-03 에이비온 주식회사 페길화된 인터페론-베타 변이체
WO2016013697A1 (ko) * 2014-07-24 2016-01-28 에이비온 주식회사 인터페론-베타 변이체의 폴리에틸렌글리콜 배합체
KR101838919B1 (ko) 2015-03-03 2018-03-15 에이비온 주식회사 인간 인터페론-베타 변이체가 접합된 면역사이토카인 및 이의 제조방법
US20210009720A1 (en) * 2015-03-03 2021-01-14 Genopharm Inc. Human interferon-beta variant conjugated immunocytokine and method for preparing same
WO2016163764A2 (ko) * 2015-04-07 2016-10-13 에이비온 주식회사 인터페론 베타 변이체의 안정화 제제
KR102666000B1 (ko) 2016-07-29 2024-05-14 서울대학교 산학협력단 cFLIP siRNA를 포함하는 인터페론 베타 저항성 암 질환 치료용 또는 감작용 조성물
KR101943160B1 (ko) 2016-10-06 2019-01-30 에이비온 주식회사 인터페론 베타 변이체의 안정화 제제
KR101955366B1 (ko) 2017-06-02 2019-03-07 인제대학교 산학협력단 인터페론 베타-엘라스틴 재조합 단백질 및 이의 생산방법
CN108117595B (zh) * 2018-02-28 2020-06-26 中国科学院微生物研究所 一种犬α干扰素的制备及其应用
KR20210021861A (ko) * 2019-08-19 2021-03-02 (주)제노팜 사람 표피성장인자수용체 2 양성 암을 치료하기 위한 인터페론-베타 변이체 면역사이토카인의 용도 및 환자 선별 방법
CN116075523A (zh) * 2020-04-29 2023-05-05 基因制药株式会社 具有融合的干扰素-β突变蛋白和抗体的重组蛋白以及包含其的药物组合物
JP2023524248A (ja) * 2020-04-29 2023-06-09 アビオン インク． 二重突然変異を有するヒトインターフェロン－ベータ変異体及びヒトインターフェロン－ベータ変異体の安全性を向上させる方法
EP4292604A4 (de) * 2021-01-13 2024-12-18 Abion Inc. Prophylaktisches verabreichungsverfahren gegen respiratorisches virus, umfassend die verabreichung von interferon-beta an eine mit potenziellem respiratorischem virus infizierte person
KR20240118230A (ko) * 2023-01-26 2024-08-05 에이비온 주식회사 인터페론 베타 건조 분말 제제 및 이의 제조방법
AU2024341598A1 (en) * 2023-09-12 2026-04-23 Heligenics Inc. Engineered interferon-beta proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
DE19717864C2 (de) 1997-04-23 2001-05-17 Fraunhofer Ges Forschung Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung
US6514729B1 (en) * 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
US6531122B1 (en) * 1999-08-27 2003-03-11 Maxygen Aps Interferon-β variants and conjugates
ATE386054T1 (de) 2002-08-31 2008-03-15 Cj Corp Glycosylierte humane interferon alpha isoform
EP1581631A4 (de) * 2002-10-01 2007-09-05 Xencor Inc Interferonvarianten mit verbesserteneigenschaften
KR100541850B1 (ko) * 2003-03-31 2006-01-11 삼성정밀화학 주식회사 인간 인터페론-베타 변이체 및 그의 제조방법

Also Published As

Publication number Publication date
US8101716B2 (en) 2012-01-24
EP1809661A1 (de) 2007-07-25
US20100003721A1 (en) 2010-01-07
ES2369088T3 (es) 2011-11-25
KR100781666B1 (ko) 2007-12-03
WO2006049423A1 (en) 2006-05-11
EP1809661B1 (de) 2011-05-18
BRPI0517932A8 (pt) 2018-05-02
KR20060039132A (ko) 2006-05-08
JP2008518631A (ja) 2008-06-05
DK1809661T3 (da) 2011-09-05
BRPI0517932A (pt) 2008-10-21
PT1809661E (pt) 2011-09-05
EP1809661A4 (de) 2008-02-06
JP4637913B2 (ja) 2011-02-23
BRPI0517932B1 (pt) 2021-10-19
CN101111519B (zh) 2012-11-07
CN101111519A (zh) 2008-01-23

Similar Documents

Publication Publication Date Title
ATE509951T1 (de) Humanes interferon-beta-mutein
ATE427763T1 (de) Ballonkatheter
ITMI20021897A1 (it) Seggiolone con dondolo per bambini.
CY1108399T1 (el) Τετραϋδροπυριδοθειοφαινια
AU301493S (en) Reciprocating saw
ATE382778T1 (de) Pumpenkombination
NL1026326A1 (nl) Patient-ligtafel.
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
FI20041641L (fi) Sovitelma silmänpainemittarissa
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
DE102004014505A1 (de) Schmuckkette mit beweglich gehaltenen Kettengliedern
ATE465741T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
ITRM20010347A1 (it) Perfezionamenti nei cinturini di orologi da polso.
ITRM20010029V0 (it) Poltrona perfezionata, in particolare per aeromobili.
FR2858695B1 (fr) Calculateur personnel.
SE0301957L (sv) Stol
BR0200192B1 (pt) cingento com três pontos de fixação.
ES1051639Y (es) Mesa de juegos.
ES1056067Y (es) Mesa suplementable.
BR8103318Y1 (pt) disposições construtivas em dedo recolhedor.
CA103210S (en) Saucer
BR8201431Y1 (pt) disposiÇço construtiva aplicada em colhedeira.
AU302348S (en) Cushions
UA6163U (en) Anthelmintic drug "anhelmint"
ES1056890Y (es) Mesa de oficina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1809661

Country of ref document: EP